These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4400180)

  • 21. Protective effect of disodium cromoglycate on rat peritoneal mast cells.
    Marshall R
    Thorax; 1972 Jan; 27(1):38-43. PubMed ID: 4111718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiallergic action of disodium cromoglycate and xanthone RS 7540.
    Gonzalez Alvarez R; Kazimierczak W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):333-9. PubMed ID: 6135406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of allergic reactions by a novel phenanthroline ICI 74,917.
    Evans DP; Gilman DJ; Thomson DS; Waring WS
    Nature; 1974 Aug; 250(467):592-3. PubMed ID: 4136035
    [No Abstract]   [Full Text] [Related]  

  • 24. BRL 22321, a compound that has mast cell stabilizing activity similar to that of disodium cromoglycate and in addition has smooth muscle relaxing activity.
    Spicer BA; Ross JW; Clarke GD; Harling EJ; Hassall PA; Smith H; Taylor JF
    Agents Actions; 1983 Jun; 13(4):301-9. PubMed ID: 6193695
    [No Abstract]   [Full Text] [Related]  

  • 25. The activity of sodium cromoglycate analogues in human lung in vitro: a comparison with rat passive cutaneous anaphylaxis and clinical efficacy.
    Church MK; Gradidge CF
    Br J Pharmacol; 1980 Oct; 70(2):307-11. PubMed ID: 6159030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of disodium cromoglycate and PGF2 alpha on acute cutaneous reactions of the guinea pig and rat.
    Taylor WA
    Int Arch Allergy Appl Immunol; 1973; 45(1):82-3. PubMed ID: 4199407
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunopharmacologic properties of WY-16,922, a new orally effective antiallergic agent.
    Rosenthale ME; Begany AJ; Dervinis A; Sellstedt J; Guinosso C; Gluckman MI
    J Pharmacol Exp Ther; 1976 Apr; 197(1):153-62. PubMed ID: 57234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of nifedipine and cromolyn sodium on skin reactions and 45Ca uptake and histamine release in rat mast cells induced by various stimulating agents.
    Tanizaki Y; Akagi K; Lee KN; Townley RG
    Int Arch Allergy Appl Immunol; 1983; 72(2):102-9. PubMed ID: 6192096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of in vivo and in vitro inhibition of the anaphylactic mechanism by beta-adrenergic stimulants and disodium cromoglycate.
    Assem ES; Richter AW
    Immunology; 1971 Nov; 21(5):729-39. PubMed ID: 4107218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
    Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibiting effect of disodium chromoglycate (Intal) on passive cutaneous anaphylaxis in rats].
    Sudo M; Yoshida T
    Arerugi; 1970 Apr; 19(4):250-9. PubMed ID: 5448916
    [No Abstract]   [Full Text] [Related]  

  • 32. The inhibition by disodium cromoglycate in vitro of anaphylactically induced histamine release from rat peritoneal mast cells.
    Kusner EJ; Dubnick B; Herzig DJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):41-6. PubMed ID: 4119619
    [No Abstract]   [Full Text] [Related]  

  • 33. Mode of action and indication for disodium cromoglycate (DSCG).
    Kunkel G; Baumer FE; Okuda M; van Cauwenberge P
    Allergol Immunopathol (Madr); 1985; 13(4):285-9. PubMed ID: 2417468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chrysin suppresses mast cell-mediated allergic inflammation: involvement of calcium, caspase-1 and nuclear factor-κB.
    Bae Y; Lee S; Kim SH
    Toxicol Appl Pharmacol; 2011 Jul; 254(1):56-64. PubMed ID: 21515303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of sodium 5,6-dimethyl-2-nitroindanedione on anaphylactic reactions in vitro.
    Sharpe TJ; Ross JW; Spicer BA
    Agents Actions; 1978 Apr; 8(3):199-202. PubMed ID: 78665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of disodium cromoglycate on phospholipase A activity. Studies with egg yolk and isolated mast cell systems.
    Hines MC; Moss GF; Cox JS
    Biochem Pharmacol; 1972 Jan; 21(2):171-9. PubMed ID: 4118943
    [No Abstract]   [Full Text] [Related]  

  • 37. Passive cutaneous anaphylaxis in the rat, induced with two homologous reagin-like antibodies and its specific inhibition with disodium cromoglycate.
    Goose J; Blair AM
    Immunology; 1969 Jun; 16(6):749-60. PubMed ID: 4306785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enigma of disodium cromoglycate action on mast cells.
    Krüger PG; Bloom GD
    Int Arch Allergy Appl Immunol; 1979; 60(1):110-4. PubMed ID: 88418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement by reproterol of the ability of disodium cromoglycate to stabilize rat mastocytes.
    Eleno N; Gajate E; Macias J; Garay RP
    Pulm Pharmacol Ther; 1999; 12(1):55-60. PubMed ID: 10208836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative modes of action of sodium cromoglycate.
    Richards IM; Dixon M; Jackson DM; Vendy K
    Agents Actions; 1986 Jun; 18(3-4):294-300. PubMed ID: 3092596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.